Research material and lot documents
GHK-Cu powder is a material description; its compound identity and the supplied lot need separate records. The primary copper-complex paper and FDA substance identity record provide reference identities.
Material destination: GHK-Cu 50 mg research listing at Curo.
Match the complete compound name to the material being offered. Prezatide Copper identity record.
Keep free GHK's formula and weight with its PubChem record.
Follow the offered lot to its report: Curo lot-certificate library.
GHK is glycyl-L-histidyl-L-lysine. GHK-Cu is its copper(II) complex. Freedman and colleagues' solution study reported a 1:1 complex under its experimental conditions. 1982 primary chemistry record.
The FDA substance record maps PREZATIDE COPPER, COPPER TRIPEPTIDE-1, GHK COMPLEX WITH COPPER and 89030-95-5. PubChem CID 73587 gives the free peptide the formula C14H24N6O4 and reference weight 340.38 g/mol.
Compare the listing and report names with the appropriate reference. Ask the supplier to resolve a mismatched identifier, salt form or analyte name.
The GHK-Cu copper peptide identity and research record explains the names and study settings.
Copper tripeptide-1 appears in the CIR cosmetic ingredient assessment. That report addresses specified cosmetic ingredient uses. It does not supply a result for an offered laboratory lot.
Read the listing's product description and intended purpose. For laboratory material destinations, open the Curo research catalog or GHK-Cu research category at Curo.
Compare the lot identifier on the offered material with the report's sample and lot fields.
Read the report issuer, report identifier, date and verification link.
Check the analyte name against the copper-complex record or free-peptide record as appropriate.
Record what species or property each method measured. The 1982 chemistry paper used optical, EPR and electron spin-echo measurements to examine copper coordination. For a commercial lot, look for that lot's own evidence supporting its declared identity.
If a report gives a peptide identity result or a chromatographic area percentage, check what supports the copper-complex description. Leave an absent measurement marked as unreported and ask the issuer to clarify it. The Curo testing description is the supplier's explanation of its documentation.
The GHK-Cu 50 mg research listing at Curo is the single-compound destination. The GHK-Cu research kit at Curo is a second material link. Follow the listing's lot references into the Curo lot-certificate library and read the actual report.
It names the offered material. To compare listings, check their declared compound identity and sample-linked documentation. The FDA reference record supplies names and identifiers, not a result for the lot.
The CIR assessment concerns specified cosmetic ingredient uses. A lot report concerns its identified sample and measurements.
Open the GHK-Cu 50 mg research listing at Curo and compare the stated material with its Curo lot-certificate destination.